Cargando…

Intestinal CREBH overexpression prevents high-cholesterol diet-induced hypercholesterolemia by reducing Npc1l1 expression

OBJECTIVE: The transcription factor cyclic AMP-responsive element-binding protein H (CREBH, encoded by Creb3l3) is highly expressed in the liver and small intestine. Hepatic CREBH contributes to glucose and triglyceride metabolism by regulating fibroblast growth factor 21 (Fgf21) expression. However...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kikuchi, Takuya, Orihara, Kana, Oikawa, Fusaka, Han, Song-iee, Kuba, Motoko, Okuda, Kanako, Satoh, Aoi, Osaki, Yoshinori, Takeuchi, Yoshinori, Aita, Yuichi, Matsuzaka, Takashi, Iwasaki, Hitoshi, Yatoh, Shigeru, Sekiya, Motohiro, Yahagi, Naoya, Suzuki, Hiroaki, Sone, Hirohito, Nakagawa, Yoshimi, Yamada, Nobuhiro, Shimano, Hitoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081412/ https://www.ncbi.nlm.nih.gov/pubmed/27818935 http://dx.doi.org/10.1016/j.molmet.2016.09.004

Ejemplares similares

CREBH Improves Diet-Induced Obesity, Insulin Resistance, and Metabolic Disturbances by FGF21-Dependent and FGF21-Independent Mechanisms
por: Satoh, Aoi, et al.
Publicado: (2020)

Selective peroxisome proliferator‐activated receptor‐α modulator K‐877 efficiently activates the peroxisome proliferator‐activated receptor‐α pathway and improves lipid metabolism in mice
por: Takei, Kenta, et al.
Publicado: (2017)

Hyperlipidemia and hepatitis in liver-specific CREB3L3 knockout mice generated using a one-step CRISPR/Cas9 system
por: Nakagawa, Yoshimi, et al.
Publicado: (2016)

CREBH regulation of lipid metabolism through multifaceted functions that improve arteriosclerosis
por: Nakagawa, Yoshimi, et al.
Publicado: (2022)

Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice
por: Suzuki-Kemuriyama, Noriko, et al.
Publicado: (2016)

CREBH Systemically Regulates Lipid Metabolism by Modulating and Integrating Cellular Functions
por: Nakagawa, Yoshimi, et al.
Publicado: (2021)

CREB3L3 controls fatty acid oxidation and ketogenesis in synergy with PPARα
por: Nakagawa, Yoshimi, et al.
Publicado: (2016)

CREBH Regulates Systemic Glucose and Lipid Metabolism
por: Nakagawa, Yoshimi, et al.
Publicado: (2018)

Absence of Elovl6 attenuates steatohepatitis but promotes gallstone formation in a lithogenic diet-fed Ldlr(−/−) mouse model
por: Kuba, Motoko, et al.
Publicado: (2015)

Rhomboid protease RHBDL4/RHBDD1 cleaves SREBP-1c at endoplasmic reticulum monitoring and regulating fatty acids
por: Han, Song-Iee, et al.
Publicado: (2023)

Octacosanol and policosanol prevent high-fat diet-induced obesity and metabolic disorders by activating brown adipose tissue and improving liver metabolism
por: Sharma, Rahul, et al.
Publicado: (2019)

Deciphering genetic signatures by whole exome sequencing in a case of co-prevalence of severe renal hypouricemia and diabetes with impaired insulin secretion
por: Sekiya, Motohiro, et al.
Publicado: (2020)

Exploratory analysis using machine learning of predictive factors for falls in type 2 diabetes
por: Suzuki, Yasuhiro, et al.
Publicado: (2022)

L-Asparaginase-Induced Continuous Hyperglycemia With Type 1 Diabetes-Related Antibodies and HLA Genotypes: A Case Study
por: Furuta, Yasuhisa, et al.
Publicado: (2022)

Palmitate Impairs and Eicosapentaenoate Restores Insulin Secretion Through Regulation of SREBP-1c in Pancreatic Islets
por: Kato, Toyonori, et al.
Publicado: (2008)

A Rare Coexistence of Pheochromocytoma and Parkinson's Disease With Diagnostic Challenges
por: Matsumura-Matsuda, Erika, et al.
Publicado: (2017)

Obesity-induced metabolic imbalance allosterically modulates CtBP2 to inhibit PPAR-alpha transcriptional activity
por: Saito, Kenji, et al.
Publicado: (2023)

Enterohepatic Transcription Factor CREB3L3 Protects Atherosclerosis via SREBP Competitive Inhibition
por: Nakagawa, Yoshimi, et al.
Publicado: (2020)

The Peroxisome Proliferator-Activated Receptor α (PPARα) Agonist Pemafibrate Protects against Diet-Induced Obesity in Mice
por: Araki, Masaya, et al.
Publicado: (2018)

Relationships between Cognitive Function and Odor Identification, Balance Capability, and Muscle Strength in Middle-Aged Persons with and without Type 2 Diabetes
por: Midorikawa, Manabu, et al.
Publicado: (2021)

Circulating Malondialdehyde-Modified LDL-Related Variables and Coronary Artery Stenosis in Asymptomatic Patients with Type 2 Diabetes
por: Fujihara, Kazuya, et al.
Publicado: (2015)

Effects of Branched-Chain Amino Acids on Skeletal Muscle, Glycemic Control, and Neuropsychological Performance in Elderly Persons with Type 2 Diabetes Mellitus: An Exploratory Randomized Controlled Trial
por: Matsuda, Takaaki, et al.
Publicado: (2022)

Rapid manipulation of mitochondrial morphology in a living cell with iCMM
por: Miyamoto, Takafumi, et al.
Publicado: (2021)

FoxO-KLF15 pathway switches the flow of macronutrients under the control of insulin
por: Takeuchi, Yoshinori, et al.
Publicado: (2021)

The transcriptional corepressor CtBP2 serves as a metabolite sensor orchestrating hepatic glucose and lipid homeostasis
por: Sekiya, Motohiro, et al.
Publicado: (2021)

Insulin‐dependent and ‐independent regulation of sterol regulatory element‐binding protein‐1c
por: Matsuzaka, Takashi, et al.
Publicado: (2013)

New liver–β‐cell axis that controls insulin secretory capacity
por: Matsuzaka, Takashi, et al.
Publicado: (2014)

Molecular mechanisms involved in hepatic steatosis and insulin resistance
por: Matsuzaka, Takashi, et al.
Publicado: (2011)

GLUT12: a second insulin‐responsive glucose transporters as an emerging target for type 2 diabetes
por: Matsuzaka, Takashi, et al.
Publicado: (2011)

Novel role for the CRTC2 in lipid homeostasis
por: Matsuzaka, Takashi, et al.
Publicado: (2016)

New perspective on type 2 diabetes, dyslipidemia and non‐alcoholic fatty liver disease
por: Matsuzaka, Takashi, et al.
Publicado: (2020)

A case of early-onset diabetes with impaired insulin secretion carrying a PAX6 gene Gln135* mutation
por: Sekiya, Motohiro, et al.
Publicado: (2022)

Protocol for rapid manipulation of mitochondrial morphology in living cells using inducible counter mitochondrial morphology (iCMM)
por: Miyamoto, Takafumi, et al.
Publicado: (2021)

CREBH Determines the Severity of Sulpyrine-Induced Fatal Shock
por: Kamiyama, Naganori, et al.
Publicado: (2013)

CREBH Couples Circadian Clock With Hepatic Lipid Metabolism
por: Zheng, Ze, et al.
Publicado: (2016)

Rho‐associated, coiled‐coil‐containing protein kinase 1 as a new player in the regulation of hepatic lipogenesis
por: Miyamoto, Takafumi, et al.
Publicado: (2019)

Predictive ability of current machine learning algorithms for type 2 diabetes mellitus: A meta‐analysis
por: Kodama, Satoru, et al.
Publicado: (2022)

Carrot Consumption Frequency Associated with Reduced BMI and Obesity through the SNP Intermediary rs4445711
por: Fujihara, Kazuya, et al.
Publicado: (2021)

New balance capability index as a screening tool for mild cognitive impairment
por: Suzuki, Yasuhiro, et al.
Publicado: (2023)

Homozygous Familial Hypercholesterolemia
por: Nohara, Atsushi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o2ctm26uv0rf7fre358ffrk4l7